Want to join the conversation?
$IDTI currently anticipates that 2Q17 interest and other will be about a $300,000 expense, and the non-GAAP tax rate to be approx. 2%. The company estimates 2Q17 share count to be about 140MM shares on a fully diluted basis. Based on the midpoint of its guidance range, $IDTI projects non-GAAP EPS for 2Q17 to be approx. $0.33.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?